But the mice vaccinated with amyloid beta peptides learned the route to the platform almost well as the normal mice, he said, showing that the vaccination had stopped the memory and cognitive losses associated with Alzheimer's. It makes them perform almost as well as but not quite as well as the normal . . . The South Florida team showed similar results, though it required its mice to perform a different task. St George-Hyslop warned that one potential hitch is the possibility that the vaccine might solve the dementia problem but prompt the body to attack its own kidneys and platelets. Amyloid beta peptides are also found in both the kidneys and platelets, both of which are extremely vulnerable to autoimmune disease.
Any new drug has potential toxicity.
Click Here to make suggestions, comments about C-Health.